YAP1 and neoplasm: According to published data, SNHG15 promotes tumor progression via serving as miRNA sponges to inhibit miRNA function, implying that in papillary thyroid carcinoma, SNHG15 controlled the YAP1-Hippo signaling pathway via miR-200-3p [25], and accelerates tumor progression in liver cancer via inhibiting miR-141-3p [31] and via sponging miR-338-3p in colorectal cancer [19].